Iovance Biotherapeutics (IOVA) Short term Debt (2012 - 2016)
Iovance Biotherapeutics (IOVA) posted quarterly Short term Debt of $250000.0 for Q4 2012, little changed quarter-over-quarter from $250000.0 in Q3 2012.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Short term Debt (2012 - 2016) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Short term Debt for 1 consecutive years, with $250000.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Short term Debt changed N/A year-over-year to $250000.0; the TTM figure through Dec 2012 stood at $250000.0 (changed N/A YoY), while the FY2012 annual figure was $250000.0, changed N/A from the prior year.
- Short term Debt was little changed at $250000.0 in Q4 2012 per IOVA's latest filing, from $250000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $250000.0 in Q3 2012 and bottomed at $250000.0 in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 86,000.00 |
| Dec 31, 2015 | 86,000.00 |
| Dec 31, 2014 | 86,000.00 |
| Dec 31, 2013 | 338,731.00 |
| Dec 31, 2012 | 250,000.00 |
| Sep 30, 2012 | 250,000.00 |